Tag
SWX: ROP
- Faeth Therapeutics signs Roche supply deal for breast cancer trial
- Climb Bio reports 38% immunologic remission in kidney trial
- DiaMedica Therapeutics reaches 200 patients in pivotal stroke trial
- TG Therapeutics reports seven-year BRIUMVI disability and safety findings
- Waters Corporation and Quest Diagnostics plan nationwide home HPV screening
- ANI Pharmaceuticals reports Phase 4 eye‑implant trial met both endpoints
- Roche reports vamikibart vision gains through week 52 in two trials
- Roche Holding AG gains FDA approval for Tecentriq in stage III dMMR colon cancer
- Surrozen gains FDA IND clearance for SZN‑8141 macular edema trial